paroxetine has been researched along with Anankastic Personality in 134 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 38 (28.36) | 18.2507 |
| 2000's | 83 (61.94) | 29.6817 |
| 2010's | 10 (7.46) | 24.3611 |
| 2020's | 3 (2.24) | 2.80 |
| Authors | Studies |
|---|---|
| Arıkan, MK; İlhan, R; Mat, MC; Oba, MÇ | 1 |
| Aljhani, S | 1 |
| Chatard, A; Harika-Germaneau, G; Hashemian, F; Jaafari, N; Lafay-Chebassier, C; Langbour, N; Millet, B; Patri, S; Pérault-Pochat, MC; Solinas, M | 1 |
| Bejerot, S; Engström, I; Humble, MB; Uvnäs-Moberg, K | 1 |
| Patterson, B; Van Ameringen, M | 1 |
| Gola, M; Potenza, MN | 1 |
| Denys, D; Vulink, N; Zantvoord, JB | 1 |
| Andersen, EW; Carey, PD; Fineberg, N; Lochner, C; Seedat, S; Stein, DJ | 1 |
| Kim, SH; Lee, HY; Lee, MS | 1 |
| Furukawa, TA; Murata, Y; Nakaaki, S | 1 |
| Saxena, S | 1 |
| Conrad, R; Geiser, F; Imbierowicz, K; Liedtke, R; Wegener, I | 1 |
| Amano, N; Harada, Y; Hayashida, A; Imai, J; Sasayama, D; Sugiyama, N | 1 |
| Hayashida, K; Kiriike, N; Matsunaga, H; Nagata, T; Ohya, K; Stein, DJ | 1 |
| Bhutada, PS; Borkar, SS; Dhumal, B; Jain, NS; Mundhada, YR; Umathe, SN | 1 |
| Adamopoulou, A; Bozikas, VP; Garyfallos, G; Katsigiannopoulos, K; Papazisis, G | 1 |
| Hayashida, K; Kiriike, N; Matsunaga, H; Nagata, T; Stein, DJ | 1 |
| Fineberg, NA; Hollander, E; Legault, M; Marteau, F; Stein, DJ | 1 |
| Krass, M; Rünkorg, K; Volke, V; Wegener, G | 1 |
| Apostolova, I; Block, S; Buchert, R; Clausen, M; Conradi, M; Fricke, S; Gensichen, S; Hand, I; Obrocki, J; Osen, B; Rufer, M; Schröder-Hartwig, K; Tabrizian, S; Weiss, A | 1 |
| Nagata, T; Nakajima, T; Teo, AR; van Vliet, I; Yamada, H; Yoshimura, C | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Mishima, K; Nagao, M; Oishi, R; Okuno, R; Shirakawa, A | 1 |
| Denys, D; van Megen, H; Westenberg, H | 1 |
| Denys, DA; Glas, G; Tenney, NH; van Megen, HJ; Westenberg, HG | 1 |
| Baxter, LR; Brody, AL; Ho, ML; Maidment, KM; Saxena, S; Zohrabi, N | 1 |
| Erdoğan, K; Toros, F | 1 |
| Denys, D; van Megen, HJ; Westenberg, HG | 1 |
| Baroni, S; Cassano, GB; Di Nasso, E; Giannaccini, G; Marazziti, D; Masala, I; Mungai, F | 1 |
| Bolwig, TG; Hansen, ES; John, ER; Prichep, LS | 1 |
| Cedro, C; D'Amico, G; D'Arrigo, C; Di Rosa, AE; La Torre, D; Muscatello, MR; Pandolfo, G; Spina, E; Zoccali, R | 1 |
| Ohmori, T; Sumitani, S | 1 |
| Kiriike, N | 1 |
| Biederman, J; Carpenter, D; Emslie, G; Farrell, C; Geller, DA; Mullin, B; Stewart, SE; Wagner, KD | 1 |
| Boldrini, M; Placidi, GF; Rossi, M | 1 |
| Ninan, PT | 1 |
| Burger, H; de Geus, F; Denys, D; van Megen, H; Westenberg, H | 1 |
| Broocks, A; Hohagen, F; Kordon, A | 1 |
| Denys, D; van der Wee, N; van Megen, HJ; Westenberg, HG | 2 |
| Allen, A; Burnham, DB; Hollander, E; Oakes, R; Steiner, M; Wheadon, DE | 1 |
| Callebert, J; Chabane, N; Delorme, R; Falissard, B; Launay, JM; Leboyer, M; Mouren-Siméoni, MC; Rouillon, F | 1 |
| Banerjee, SP; Ivey, J; Lorch, E; MacMillan, S; Madden, R; McMeniman, M; Moore, GJ; Rosenberg, DR; Szeszko, PR | 1 |
| Avci, A; Diler, RS; Kibar, M | 1 |
| Swedo, S; Vitiello, B | 1 |
| Asai, M; Higuchi, T; Kamijima, K; Matsunaga, H; Murasaki, M; Nakajima, T; Taga, C | 1 |
| Albert, U; Bogetto, F; Maina, G; Salvi, V | 1 |
| Carpenter, DJ; Emslie, G; Gardiner, C; Geller, DA; Machin, A; Murphy, T; Perera, P; Wagner, KD; Wetherhold, E | 1 |
| Doljansky, J; Joel, D; Rehavi, M; Roz, N | 1 |
| Ramasubbu, R | 1 |
| Ballenger, JC | 1 |
| Betancur, C; Callebert, J; Chabane, N; Delorme, R; Laplanche, JL; Launay, JM; Leboyer, M; Mouren-Simeoni, MC | 1 |
| Denys, DA; Tenneij, NH; van Megen, HJ; Westenberg, HG | 1 |
| Denys, D; Fluitman, S; Heijnen, C; Kavelaars, A; Westenberg, HG | 1 |
| Braam, AW; Cath, DC; Hoogendijk, WJ; Visser, S | 1 |
| Bartolic, EI; Carpenter, DJ; Danoff, TM; Findling, RL; Fong, R; Gaedigk, A; Gomeni, R; Leeder, JS; Nucci, G; Piergies, AA | 1 |
| Katz, AW; Velayudhan, L | 1 |
| Dell'Osso, B; Hollander, E | 1 |
| Carpenter, DJ; Fong, R; Horrigan, JP; Krulewicz, S; Lipschitz, A; Perera, P; Wagner, KD | 1 |
| Baxter, LR; Brody, AL; Maidment, KM; Saxena, S | 1 |
| Bares, M; Horácek, J; Kopecek, M; Novák, T; Pasková, B; Prasko, J; Záleský, R | 1 |
| Aoki, M; Kamijima, K | 1 |
| Corace, E; De Fazio, P; De Fazio, S; De Sarro, G; Gallelli, L; Garcia, CS | 1 |
| Bailly, D | 1 |
| Hirayasu, Y; Karashima, A; Otsuka, T; Shioya, H; Sugiyama, N; Togo, T; Uehara, K; Yoshimi, A | 1 |
| Harada, M; Kubo, H; Ohmori, T; Sumitani, S | 1 |
| Egashira, N; Fujiwara, M; Harada, S; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Okuno, R; Orito, K | 1 |
| Higashiyama, S; Kawabe, J; Kiriike, N; Kohagura, K; Matsui, T; Matsunaga, H; Saxena, S | 1 |
| Andersen, EW; Fineberg, N; Stein, DJ; Tonnoir, B | 1 |
| de la Rosa M, A; De Las Cuevas, C; Sanz, EJ; Troyano, JM | 1 |
| Knopf, U; Kuwilsky, A; Zink, M | 1 |
| Deforce, D; Denys, D; Van Nieuwerburgh, F; Westenberg, HG | 1 |
| Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
| Cameron, AJ; Liang, R; Ng, BK; Rahman, H | 1 |
| Ağargün, MY; Aşkin, R; Aydin, A; Beşiroğlu, L; Uğuz, F; Yilmaz, E | 1 |
| Jefferys, D; Moore, KA | 1 |
| Christensen, RC | 1 |
| Corbett, R; Kongsamut, S; Roehr, J; Woods, A | 1 |
| Danos, P; Höflich, G; Kasper, S; Möller, HJ; Scholl, HP | 1 |
| Bruun, RD; Budman, CL; Sherling, M | 1 |
| Barnhill, LJ; Horrigan, JP | 1 |
| Deltito, JA | 1 |
| Buttolph, ML; Cyr, P; Jenike, MA; Keuthen, NJ; Minichiello, WE; Ricciardi, JA | 1 |
| Dancu, C; Kaye, NS | 1 |
| Barr, LC; Goodman, WK; Price, LH | 1 |
| Bardgett, ME; Csernansky, JG; Jackson, JL; Nelson, EC; Sheline, YI | 1 |
| Blier, P; Bouchard, C; el Mansari, M | 1 |
| Bastani, AJ; Bastani, JB; Troester, MM | 1 |
| Olivera, AA | 1 |
| Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
| Judge, R; Zohar, J | 1 |
| Keith, SJ; Nurnberg, HG; Paxton, DM | 1 |
| Rey, JM; Wever, C | 1 |
| Cassano, GB; Gemignani, A; Giannaccini, G; Lucacchini, A; Marazziti, D; Milanfranchi, A; Pfanner, C; Presta, S; Rossi, A | 1 |
| Murray, MG; Newman, RM | 1 |
| Bellodi, L; Bianchi, L; Mundo, E | 1 |
| Benfield, P; Gunasekara, NS; Noble, S | 1 |
| de Zwaan, M; Frey, R; Heiden, A; Kasper, S; Presslich, O | 1 |
| MacMaster, FP; Moore, GJ; Rosenberg, DR; Stewart, C | 1 |
| Baker, P; Black, DW; Blum, N; Clancy, G; Gable, J; Monahan, P | 1 |
| Abel, L; Holzer, JC; Iqbal, JC | 1 |
| Bruun, RD; Budman, CL | 1 |
| Avci, A; Diler, RS | 1 |
| Agid, O; Lerer, B | 1 |
| Pigott, TA; Seay, SM | 1 |
| Green, AI; Patel, JK; Strous, RD; Zimmet, S | 1 |
| Bell, C; Nutt, D | 1 |
| Akiskal, HS; Cassano, GB; Marazziti, D; Rossi, A | 1 |
| Carroll, E; Fitzgerald, KD; Rosenberg, DR; Stewart, CM; Tawile, V | 1 |
| Anisman, H; Lapierre, YD; Ravindran, AV | 1 |
| Kraus, JE | 1 |
| Alborzian, S; Baxter, LR; Brody, AL; Colgan, M; Dunkin, JJ; Maidment, KM; Phelps, ME; Saxena, S | 1 |
| Baroni, S; Cassano, GB; Dell'Osso, L; Giannaccini, G; Lucacchini, A; Marazziti, D; Masala, I; Pfanner, C; Presta, S; Rossi, A | 1 |
| Boffa, E; Lofchy, J | 1 |
| Dannon, PN; Grunhaus, LJ; Hirschmann, S; Iancu, I; Sasson, Y; Zohar, J | 1 |
| Gilbert, AR; Keshavan, MS; Mac Master, FP; Moore, GJ; Narula, V; Paulson, LA; Rosenberg, DR; Stewart, CM | 1 |
| Alborzian, S; Baxter, LR; Brody, AL; Demaree, HA; Fairbanks, LA; Maidment, KM; Saxena, S | 1 |
| Aldenhoff, JB; Friege, L; Göder, R; Grohmann, R; Treskov, V | 1 |
| Fitzgerald, KD; Keshavan, MS; MacMaster, FP; Moore, GJ; Rosenberg, DR; Stewart, CM | 1 |
| Beauclair, L; Chouinard, G; Margolese, HC; Rubino, M | 1 |
| Bejerot, S; Bengtsson, F; Bergqvist, PB; Humble, M | 1 |
| Cassano, GB; Conti, L; Dell'Osso, L; Gemignani, A; Marazziti, D; Pfanner, C; Presta, S; Rossi, A | 1 |
| Koran, LM; Pallanti, S; Quercioli, L | 1 |
| Baerg, EA; Garland, EJ | 1 |
| Bolton, J; MacMillan, S; Moore, GJ; Rosenberg, DR; Stewart, CM | 1 |
| Bellodi, L; Cavallini, MC; Cavedini, P; Diaferia, G; Erzegovesi, S; Locatelli, M | 1 |
| Grant, JE; Kim, SW | 1 |
| Anderson, GM; Kema, IP; Minderaa, RB; Mulder, EJ | 1 |
| Neel, JL; Stevens, VM; Stewart, JE | 1 |
| Alborzian, S; Baxter, LR; Brody, AL; Ho, MK; Ho, ML; Huang, SC; Maidment, KM; Saxena, S; Wu, HM; Zohrabi, N | 1 |
| D'Addio, K; Prater, JF | 1 |
| Bolwig, TG; Hansen, ES; Hasselbalch, S; Law, I | 1 |
| Goodman, WK; McDougle, CJ; Price, LH | 1 |
15 review(s) available for paroxetine and Anankastic Personality
| Article | Year |
|---|---|
Recent advances in compulsive hoarding.
Topics: Brain; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 22; Cognitive Behavioral Therapy; Food; Glucose; Humans; Memory Disorders; Neuropsychological Tests; Obsessive-Compulsive Disorder; Paroxetine; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors | 2008 |
[The treatment of OCD].
Topics: Antipsychotic Agents; Behavior Therapy; Clomipramine; Drug Therapy, Combination; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors | 2003 |
[Eating disorders].
Topics: Comorbidity; Feeding and Eating Disorders; Fluvoxamine; Humans; Nutritional Support; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Reference Standards; Selective Serotonin Reuptake Inhibitors; Serotonin | 2003 |
Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetine.
Topics: Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2003 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
Remission rates in patients with anxiety disorders treated with paroxetine.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Female; Humans; Longitudinal Studies; Male; Middle Aged; Obsessive-Compulsive Disorder; Panic Disorder; Paroxetine; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome | 2004 |
Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
Topics: Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Obsessive-Compulsive Disorder; Paroxetine; Practice Patterns, Physicians'; Treatment Outcome | 2006 |
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted | 2006 |
[Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review].
Topics: Anesthesia, General; Drug Interactions; Dystonia; Enzyme Inhibitors; Eye Movements; Female; Humans; Infusions, Intravenous; Methylene Blue; Middle Aged; Obsessive-Compulsive Disorder; Parathyroidectomy; Paroxetine; Postoperative Complications; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Tachycardia | 2008 |
Pathological hoarding.
Topics: Age Factors; Animals; Cognitive Behavioral Therapy; Comorbidity; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2008 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Nausea; Obsessive-Compulsive Disorder; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1998 |
A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Topics: Clinical Trials as Topic; Clomipramine; Double-Blind Method; Humans; Meta-Analysis as Topic; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Obsessive-compulsive disorder: identification, neurobiology, and treatment.
Topics: Adult; Behavior Therapy; Child; Combined Modality Therapy; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2002 |
Pharmacotherapy of obsessive compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline | 1992 |
36 trial(s) available for paroxetine and Anankastic Personality
| Article | Year |
|---|---|
Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo controlled study.
Topics: Adolescent; Adult; Clomipramine; Double-Blind Method; Humans; Middle Aged; Obsessive-Compulsive Disorder; Oxytocin; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2013 |
Escitalopram in obsessive-compulsive disorder: response of symptom dimensions to pharmacotherapy.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Personality Assessment; Personality Inventory; Psychometrics; Treatment Outcome | 2008 |
A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.
Topics: Adult; Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Cognitive Behavioral Therapy; Combined Modality Therapy; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Fluvoxamine; Follow-Up Studies; Humans; Long-Term Care; Male; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Quetiapine Fumarate; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2009 |
Clinical features and treatment characteristics of compulsive hoarding in Japanese patients with obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Compulsive Behavior; Female; Fluvoxamine; Humans; Japan; Male; Obsessive-Compulsive Disorder; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2010 |
Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study.
Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Cyclohexanols; Dibenzothiazepines; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder.
Topics: Adult; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Social Behavior; Venlafaxine Hydrochloride | 2003 |
Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Drug Resistance; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Pirenzepine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Weight Gain | 2003 |
Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
Topics: Adolescent; Child; Comorbidity; Double-Blind Method; Female; Humans; Male; Mental Disorders; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors | 2003 |
A score for predicting response to pharmacotherapy in obsessive-compulsive disorder.
Topics: Adolescent; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Dose-Response Relationship, Drug; Double-Blind Method; Factor Analysis, Statistical; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Predictive Value of Tests; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2003 |
A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Patient Dropouts; Psychological Tests; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.
Topics: Acute Disease; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Long-Term Care; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Prospective Studies; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2003 |
Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
Topics: Adolescent; Adult; Binding Sites; Biomarkers; Blood Platelets; Carrier Proteins; Cell Membrane; Child; Diet; Female; France; Humans; Imipramine; Inositol Phosphates; Iodine Isotopes; Lysergic Acid Diethylamide; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Radiochemistry; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome; Tritium; Tryptophan | 2004 |
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Cross-Over Studies; Cyclohexanols; Double-Blind Method; Drug Resistance; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary findings.
Topics: Adolescent; Amygdala; Antidepressive Agents, Second-Generation; Child; Female; Follow-Up Studies; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Obsessive-Compulsive Disorder; Paroxetine; Time Factors | 2004 |
Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder.
Topics: Adolescent; Cerebrovascular Circulation; Child; Depressive Disorder; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2004 |
Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Japan; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Personality Inventory; Psychometrics; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2004 |
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2004 |
Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adolescent; Child; Double-Blind Method; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2004 |
Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment.
Topics: Adult; Ambulatory Care; Behavior Therapy; Combined Modality Therapy; Cyclohexanols; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder.
Topics: Adult; Cyclohexanols; Cytokines; Double-Blind Method; Female; Humans; Killer Cells, Natural; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2006 |
Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Area Under Curve; Child; Cytochrome P-450 CYP2D6; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychometrics; Time Factors | 2006 |
Paroxetine treatment of compulsive hoarding.
Topics: Adult; Anxiety; Compulsive Behavior; Depression; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2007 |
The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study.
Topics: Adult; Antidepressive Agents, Second-Generation; Combined Modality Therapy; Double-Blind Method; Drug Resistance; Electric Stimulation Therapy; Female; Humans; Male; Neuropsychological Tests; Obsessive-Compulsive Disorder; Paroxetine; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Statistics, Nonparametric; Transcranial Magnetic Stimulation; Treatment Outcome | 2006 |
Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Patient Dropouts; Placebos; Reference Standards; Remission Induction; Treatment Outcome | 2007 |
Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial.
Topics: Adult; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Polymorphism, Genetic; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
Topics: Adolescent; Adult; Aged; Clomipramine; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1996 |
Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Single-Blind Method | 1997 |
Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder.
Topics: Age Factors; Age of Onset; Anxiety Disorders; Cognitive Behavioral Therapy; Comorbidity; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Treatment Outcome | 1998 |
Paroxetine treatment of episodic rages associated with Tourette's disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Pilot Projects; Rage; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tic Disorders; Tourette Syndrome; Treatment Outcome | 1998 |
Paroxetine open-label treatment of pediatric outpatients with obsessive-compulsive disorder.
Topics: Adolescent; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Pindolol; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2000 |
Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.
Topics: Adolescent; Age Factors; Child; Female; Humans; Magnetic Resonance Imaging; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Sex Factors; Thalamus; Treatment Outcome | 2000 |
Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder.
Topics: Adult; Double-Blind Method; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin | 2001 |
Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.
Topics: Adolescent; Adult; Double-Blind Method; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan | 2001 |
Personality dimensions in pathological gambling disorder and obsessive-compulsive disorder.
Topics: Adult; Double-Blind Method; Female; Gambling; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Personality Disorders; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2001 |
The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study.
Topics: Adult; Caudate Nucleus; Cerebral Cortex; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Radiopharmaceuticals; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed | 2002 |
83 other study(ies) available for paroxetine and Anankastic Personality
| Article | Year |
|---|---|
When to Choose Paroxetine Treatment in Skin-Picking Disorder: A Case Report.
Topics: Adult; Electroencephalography; Female; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Skin Diseases | 2023 |
Fluoxetine for the treatment of onychotillomania associated with obsessive-compulsive disorder: a case report.
Topics: Adolescent; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Pharmaceutical Preparations; Quality of Life | 2022 |
Impact of brain-derived neurotrophic factor Val66Met polymorphism and response to escitalopram or paroxetine in obsessive-compulsive disorder.
Topics: Brain-Derived Neurotrophic Factor; Escitalopram; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2022 |
Topiramate augmentation in a patient with obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Citalopram; Drug Synergism; Fear; Female; Fructose; Humans; Lorazepam; Obsessive-Compulsive Disorder; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate; Treatment Refusal | 2015 |
Paroxetine Treatment of Problematic Pornography Use: A Case Series.
Topics: Adult; Anti-Anxiety Agents; Behavior, Addictive; Cognitive Behavioral Therapy; Combined Modality Therapy; Erotica; Heterosexuality; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2016 |
Cognitive Behavioral Therapy for Olfactory Reference Syndrome: A Case Report.
Topics: Agnosia; Cognitive Behavioral Therapy; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2016 |
Relapse of tic symptoms in a patient diagnosed with obsessive-compulsive disorder and treated with high-dose paroxetine.
Topics: Adolescent; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Recurrence; Tics | 2008 |
Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Body Image; Delusions; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine | 2008 |
Nature against nurture: calcification in the right thalamus in a young man with anorexia nervosa and obsessive-compulsive personality disorder.
Topics: Adult; Anorexia Nervosa; Benzodiazepines; Calcinosis; Combined Modality Therapy; Dominance, Cerebral; Humans; Life Change Events; Male; Mediodorsal Thalamic Nucleus; Mianserin; Mirtazapine; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Psychotherapy; Thalamic Diseases; Tomography, X-Ray Computed | 2008 |
High-dose paroxetine treatment for an adolescent with obsessive-compulsive disorder comorbid with Asperger's disorder.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Asperger Syndrome; Dose-Response Relationship, Drug; Female; Humans; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Serotonin | 2009 |
Role of nitric oxide in obsessive-compulsive behavior and its involvement in the anti-compulsive effect of paroxetine in mice.
Topics: Analysis of Variance; Animals; Arginine; Behavior, Animal; Brain; Brain Chemistry; Male; Mice; Motor Activity; Nitric Oxide; Nitroprusside; Obsessive-Compulsive Disorder; Paroxetine | 2009 |
Obsessive-compulsive disorder following cavernous sinus thrombosis.
Topics: Cavernous Sinus Thrombosis; Humans; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Citalopram; Cost of Illness; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Health Status; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychiatric Status Rating Scales; Quality of Life; Randomized Controlled Trials as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2010 |
Nitric oxide is involved in the regulation of marble-burying behavior.
Topics: Agmatine; Animals; Arginine; Behavior, Animal; Citalopram; Imidazoles; Indazoles; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Nitric Oxide Synthase Type I; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2010 |
Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET.
Topics: Adult; Analysis of Variance; Brain; Brain Mapping; Cognitive Behavioral Therapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Linear Models; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Prospective Studies; Radionuclide Imaging; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome | 2010 |
Comorbid social withdrawal (hikikomori) in outpatients with social anxiety disorder: clinical characteristics and treatment response in a case series.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Cyclopropanes; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluvoxamine; Humans; Interview, Psychological; Japan; Male; Milnacipran; Obsessive-Compulsive Disorder; Paroxetine; Phobic Disorders; Psychotherapy, Group; Reactive Attachment Disorder; Retrospective Studies; Social Isolation; Treatment Outcome; Young Adult | 2013 |
Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice.
Topics: Aminopyridines; Amphetamines; Animals; Behavior, Animal; Fluoxetine; Indoles; Male; Mice; Mice, Inbred ICR; Motor Activity; Obsessive-Compulsive Disorder; Paroxetine; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2012 |
Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression.
Topics: Adult; Brain; Caudate Nucleus; Depressive Disorder; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Gyrus Cinguli; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Prefrontal Cortex; Probability; Prognosis; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed; Treatment Outcome | 2003 |
Paroxetine-induced enuresis.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Enuresis; Female; Humans; Obsessive-Compulsive Disorder; Paroxetine | 2003 |
Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care.
Topics: Adult; Female; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Skin | 2003 |
Decreased lymphocyte 3H-paroxetine binding in obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Binding Sites; Carrier Proteins; Female; Humans; Lymphocytes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Paroxetine; Serotonin Plasma Membrane Transport Proteins | 2003 |
Quantitative electroencephalography in OCD patients treated with paroxetine.
Topics: Adult; Brain; Electroencephalography; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2003 |
Are SSRIs safe for children?
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Depression; Fatigue; Humans; Nausea; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders | 2003 |
Paroxetine efficacy in stuttering treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Stuttering | 2003 |
Antidepressant medications in children.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Causality; Child; Depressive Disorder; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Suicide | 2004 |
Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Child; Drug Approval; Fluoxetine; France; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2004 |
Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Extinction, Psychological; Frontal Lobe; Imipramine; Male; Obsessive-Compulsive Disorder; Paroxetine; Protein Binding; Random Allocation; Rats; Rats, Wistar; Serotonin; Tritium | 2005 |
Antidepressant treatment-associated behavioural expression of hypomania: a case series.
Topics: Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Depressive Disorder, Major; Female; Humans; Irritable Mood; Ischemic Attack, Transient; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Stroke | 2004 |
Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Biomarkers; Blood Platelets; Case-Control Studies; Child; Female; Genotype; Humans; Imipramine; Inositol 1,4,5-Trisphosphate; Iodine Isotopes; Lysergic Acid Diethylamide; Male; Middle Aged; Minisatellite Repeats; Obsessive-Compulsive Disorder; Paroxetine; Radioimmunoassay; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Statistics as Topic; Statistics, Nonparametric; Tritium | 2005 |
Investigation of the syndrome of apotemnophilia and course of a cognitive-behavioural therapy.
Topics: Adult; Amputation, Surgical; Body Image; Cognitive Behavioral Therapy; Combined Modality Therapy; Depersonalization; Disabled Persons; Factitious Disorders; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychopathology; Selective Serotonin Reuptake Inhibitors; Somatoform Disorders; Syndrome | 2006 |
Late-onset obsessive-compulsive disorder: the role of stressful life events.
Topics: Aged; Antidepressive Agents, Second-Generation; Female; Humans; Life Change Events; Obsessive-Compulsive Disorder; Paroxetine; Stress, Psychological; Treatment Outcome | 2006 |
Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder.
Topics: Anticonvulsants; Drug Resistance; Drug Therapy, Combination; Female; Fructose; Humans; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Topiramate | 2006 |
Analysis of electrocardiographic data following use of paroxetine in pediatric depression and obsessive-compulsive disorder.
Topics: Adolescent; Canada; Child; Depressive Disorder; Double-Blind Method; Electrocardiography; Female; Humans; Male; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Paroxetine; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; United States | 2006 |
Generalised urticaria in a young woman treated with clomipramine and after ingestion of codfish.
Topics: Adult; Alprazolam; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Clomipramine; Drug Eruptions; Female; Food-Drug Interactions; Gadus morhua; Humans; Hypnotics and Sedatives; Meat; Obsessive-Compulsive Disorder; Paroxetine; Urticaria | 2006 |
Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depression; Drug Synergism; Female; Humans; Indoles; Isoindoles; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Thiazoles | 2007 |
Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients.
Topics: Adult; Antipsychotic Agents; Aspartic Acid; Basal Ganglia; Benzodiazepines; Dominance, Cerebral; Dose-Response Relationship, Drug; Drug Therapy, Combination; Energy Metabolism; Female; Fluvoxamine; Frontal Lobe; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Net; Obsessive-Compulsive Disorder; Olanzapine; Paroxetine; Prefrontal Cortex; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |
Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.
Topics: Animals; Behavior, Animal; Brain; Butyrates; Disease Models, Animal; Dose-Response Relationship, Drug; Ethylenediamines; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Morpholines; Obsessive-Compulsive Disorder; Paroxetine; Phenazocine; Piperazines; Psychotropic Drugs; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor; Tropanes | 2007 |
Secondary obsessive-compulsive disorder related to diaschisis after pontine infarction, successfully treated with paroxetine.
Topics: Aged; Antidepressive Agents, Second-Generation; Cerebral Infarction; Cerebrovascular Circulation; Humans; Magnetic Resonance Imaging; Male; Obsessive-Compulsive Disorder; Paroxetine; Pons; Psychiatric Status Rating Scales; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2007 |
Are psychotropics drugs used in pregnancy?
Topics: Adolescent; Adult; Antidepressive Agents; Benzodiazepines; Cesarean Section; Depressive Disorder; Drug Utilization Review; Feeding and Eating Disorders; Female; Humans; Infant, Newborn; Lithium Compounds; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Psychotropic Drugs; Spain; Surveys and Questionnaires; Treatment Outcome; Withholding Treatment | 2007 |
Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Clozapine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia, Paranoid | 2007 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
[Psychopharmacological treatment and quality of life in obsessive compulsive disorder].
Topics: Adult; Female; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2008 |
Paroxetine-induced psychotic mania.
Topics: Adult; Bipolar Disorder; Dose-Response Relationship, Drug; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine | 1995 |
Changes in paroxetine binding in the cerebral cortex of polydipsic rats.
Topics: Animals; Binding, Competitive; Cerebral Cortex; Disease Models, Animal; Drinking Behavior; Fluoxetine; Food Deprivation; Isotope Labeling; Obsessive-Compulsive Disorder; Paroxetine; Random Allocation; Rats; Thirst; Tritium | 1995 |
[Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
Topics: Adult; Antipsychotic Agents; Comorbidity; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Paroxetine; Patient Admission; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors | 1994 |
Combined pharmacotherapy risk.
Topics: Child; Drug Therapy, Combination; Haloperidol; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Tourette Syndrome | 1995 |
Paroxetine-pimozide drug interaction.
Topics: Albinism; Attention Deficit Disorder with Hyperactivity; Blindness; Child; Drug Synergism; Enuresis; Humans; Male; Mood Disorders; Obsessive-Compulsive Disorder; Paroxetine; Pimozide | 1994 |
Valproate pretreatment for the difficult-to-treat patient with OCD.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Sertraline; Treatment Outcome; Valproic Acid | 1994 |
Medication withdrawal symptoms in obsessive-compulsive disorder patients treated with paroxetine.
Topics: Adult; Dizziness; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Substance Withdrawal Syndrome | 1994 |
Paroxetine and obsessive-compulsive disorder.
Topics: Humans; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Treatment Outcome | 1994 |
Physical symptoms associated with paroxetine discontinuation.
Topics: Adult; Depressive Disorder; Female; Humans; Influenza, Human; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Substance Withdrawal Syndrome | 1994 |
Platelet paroxetine binding in major depressive disorder with and without comorbid obsessive-compulsive disorder.
Topics: Adult; Blood Platelets; Carrier Proteins; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Receptors, Drug; Selective Serotonin Reuptake Inhibitors; Serotonin | 1995 |
Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder.
Topics: Animals; Dose-Response Relationship, Drug; Fluoxetine; Frontal Lobe; Guinea Pigs; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors | 1995 |
Serotonin syndrome and fluvoxamine: a case study.
Topics: Adult; Antidepressive Agents, Second-Generation; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Psychoses, Substance-Induced; Selective Serotonin Reuptake Inhibitors; Syndrome; Time Factors | 1996 |
A case of paroxetine-induced akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Female; Humans; Obsessive-Compulsive Disorder; Paroxetine | 1996 |
Consideration of the relevance of ethological animal models for human repetitive behavioral spectrum disorders.
Topics: Acepromazine; Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Ethology; Female; Horse Diseases; Horses; Humans; Naltrexone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Opioid Peptides; Paroxetine; Reaction Time; Selective Serotonin Reuptake Inhibitors; Serotonin; Stereotyped Behavior; Stress, Psychological | 1997 |
Juvenile obsessive-compulsive disorder.
Topics: Adolescent; Child; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Personality Assessment; Prognosis; Treatment Outcome | 1997 |
Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients.
Topics: Adolescent; Adult; Blood Platelets; Brain; Carrier Proteins; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 1996 |
Paroxetine for treatment of obsessive-compulsive disorder and comorbid stuttering.
Topics: Adult; Comorbidity; Female; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Stuttering; Treatment Outcome | 1997 |
Paroxetine in a patient with obsessive-compulsive disorder, anorexia nervosa and schizotypal personality disorder.
Topics: Adult; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Female; Humans; Obsessive-Compulsive Disorder; Paroxetine; Schizotypal Personality Disorder | 1998 |
Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder.
Topics: Caudate Nucleus; Child; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Models, Neurological; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1998 |
Paroxetine and amotivational syndrome.
Topics: Cerebrovascular Disorders; Hemiplegia; Humans; Male; Middle Aged; Motivation; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Syndrome | 1998 |
SSRI-induced mania in obsessive-compulsive disorder.
Topics: Bipolar Disorder; Child; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1999 |
Risperidone augmentation of paroxetine in a case of severe, treatment-refractory obsessive-compulsive disorder without comorbid psychopathology.
Topics: Adult; Comorbidity; Dopamine Antagonists; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychiatric Status Rating Scales; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features.
Topics: Antipsychotic Agents; Clozapine; Comorbidity; Drug Therapy, Combination; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Paroxetine and its uses in psychiatry.
Topics: Antidepressive Agents, Second-Generation; Anxiety Disorders; Depression; Drug Interactions; Humans; Mental Disorders; Obsessive-Compulsive Disorder; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders | 1999 |
Alteration of the platelet serotonin transporter in romantic love.
Topics: Adult; Binding Sites; Biological Transport; Buffers; Female; Humans; Interpersonal Relations; Love; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior | 1999 |
Obsessive-compulsive spectrum disorders: effective treatment with paroxetine.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Trichotillomania | 1999 |
Treatment of kleptomania with paroxetine.
Topics: Adult; Comorbidity; Depressive Disorder; Disruptive, Impulse Control, and Conduct Disorders; Drug Administration Schedule; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1999 |
Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder.
Topics: Cerebral Cortex; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Predictive Value of Tests; Radiopharmaceuticals; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Tomography, Emission-Computed | 1999 |
Platelet [3H]paroxetine binding in patients with OCD-related disorders.
Topics: Adolescent; Adult; Blood Platelets; Carrier Proteins; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Obsessive-Compulsive Disorder; Paroxetine; Receptors, Drug; Serotonin Plasma Membrane Transport Proteins | 1999 |
Paroxetine and tardive akathisia.
Topics: Adult; Akathisia, Drug-Induced; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2000 |
Personality changes in adult subjects with major depressive disorder or obsessive-compulsive disorder treated with paroxetine.
Topics: Adult; Analysis of Variance; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Factor Analysis, Statistical; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Personality; Personality Disorders; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2000 |
Association of paroxetine with suicide attempt in obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Humans; Lorazepam; Male; Methotrimeprazine; Obsessive-Compulsive Disorder; Paroxetine; Promethazine; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted | 2000 |
Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.
Topics: Adolescent; Case-Control Studies; Caudate Nucleus; Child; Confounding Factors, Epidemiologic; Female; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Male; Obsessive-Compulsive Disorder; Occipital Lobe; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Treatment Outcome | 2000 |
Cutaneous vasculitis induced by paroxetine.
Topics: Adult; Antidepressive Agents, Second-Generation; Drug Eruptions; Female; Humans; Obsessive-Compulsive Disorder; Paroxetine; Vasculitis; Vasculitis, Leukocytoclastic, Cutaneous | 2001 |
No correlation between aggression and platelet (3)H-paroxetine binding in obsessive-compulsive disorder patients.
Topics: Adolescent; Adult; Aggression; Carrier Proteins; Child; Depression; Female; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sex Factors | 2001 |
Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
Topics: Adolescent; Anxiety Disorders; Child; Depressive Disorder; Female; Fluoxetine; Humans; Male; Motivation; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2001 |
Case study: caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD.
Topics: Brain Chemistry; Caudate Nucleus; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Obsessive-Compulsive Disorder; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors | 2001 |
Clinical predictors of drug response in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Citalopram; Clomipramine; Drug Resistance; Female; Fluvoxamine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Predictive Value of Tests; Psychological Tests; Random Allocation; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2001 |
Reactivity of serotonin in whole blood.
Topics: Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin | 2002 |
Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression.
Topics: Adult; Blood Glucose; Brain; Brain Mapping; Comorbidity; Depressive Disorder, Major; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Personality Inventory; Radiography; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Johanson-Blizzard syndrome--a case study, behavioral manifestations, and successful treatment strategies.
Topics: Abnormalities, Multiple; Adult; Aggression; Behavior Therapy; Combined Modality Therapy; Follow-Up Studies; Humans; Intellectual Disability; Male; Obsessive-Compulsive Disorder; Paroxetine; Syndrome | 2002 |